Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia-Reference-Cited by-同舟云学术

Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia

Published:2010-01 Issue:1-2 Volume:175 Page:38-42
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Bloch Boaz,Reshef Alon,Cohen Tamara,Tafla Amos,Gathas Samich,Israel Salomon,Gritsenko Inga,Kremer Ilana,Ebstein Richard P.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference38 articles.

1. Smoking cessation among Chinese young smokers: does gender and age difference matters [sic] and what are the predictors?;Abdullah;Addictive Behaviors,2006

2. Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions;Aguilar;British Journal of Psychiatry,2005

3. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial;Aubin;Addiction,2004

4. No gender difference in effectiveness of smoking cessation treatment in a Brazilian real-life setting;Chatkin;International Journal of Tuberculosis and Lung Disease,2006

5. Bupropion for smoking cessation: predictors of successful outcome;Dale;Chest,2001

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antidepressants for smoking cessation;Cochrane Database of Systematic Reviews;2023-05-24

2. Serotonin Transporter Genetic Variation and Antidepressant Response and Tolerability: A Systematic Review and Meta-Analysis;Journal of Personalized Medicine;2021-12-09

3. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis;Health Technology Assessment;2021-10

4. The Impact of Smoking Cessation on Hospitalization and Psychiatric Medication Utilization among People with Serious Mental Illness;Substance Use & Misuse;2021-06-30

5. Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis;The Lancet Psychiatry;2020-09